---
$id: https://graph.org.ai/products/commodity/51151538
$type: Product
source: UNSPSC
code: "51151538"
title: "Cevimeline hydrochloride"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cevimeline hydrochloride

**UNSPSC Code**: 51151538
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholinergic agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P81Q6V85NP. European Medicines Agency schedules Cevimeline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01186MIG. Cevimeline hydrochloride generally arises in the molecular formula 2C10H17NOS.2CLH.H2O. The term 'cevimeline hydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule cevimeline hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, CEVIMELINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Cevimeline hydrochloride bears US NLM identifiers UMLS ID C0874063 and NCI Concept Code C1337. SMILES: C[C@H]1O[C@@]2(CN3CCC2CC3)CS1.C[C@H]1O[C@@]2(CN3CCC2CC3)CS1.O.CL.CL.

